organophosphonates has been researched along with dinoprostone in 15 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | organophosphonates (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 9 (60.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolognese, B; Gelb, M; Marshall, LA; Yuan, W | 1 |
| Delaisse, JM; Eeckhout, Y; Vaes, G | 1 |
| Andersen, NH; Hanson, SR; Harker, LA; Tynan, SS; Wills, MT | 1 |
| Demetris, AJ; Han, C; Lunz, JG; Michalopoulos, G; Shelhamer, JH; Wu, T | 1 |
| Balboa, MA; Dennis, EA; Killermann Lucas, K; Varela-Nieto, I | 1 |
| Ambudkar, SV; Nandigama, K; Sauna, ZE | 1 |
| Brandt, MR; Cummons, TA; Potestio, L; Rosenzweig-Lipson, S; Sukoff, SJ | 1 |
| Albano, RM; Assis, MC; Bozza, PT; Coelho, MG; Gayer, CR; Lopes, UG; Marques, EA; Nascimento, DO; Paiva, DD; Plotkowski, MC; Raymond, B; Saliba, AM; Silva, MC; Touqui, L | 1 |
| Borgeat, P; Bourgoin, SG; Flamand, N; Lemieux, L; Picard, S; Pouliot, M | 1 |
| Haneji, T; Nagata, T; Shinohara, H; Yoshida, K | 1 |
| da Fonseca Pacheco, CM; da Fonseca Pacheco, D; de Castro Perez, A; de Francischi, JN; Duarte, ID; Klein, A | 1 |
| Lewis, AW; Neuendorff, DA; Randel, RD; Weems, CW; Weems, YS | 1 |
| Berenbaum, F; Gosset, M; Holzenberger, M; Jacques, C; Mladenovic, Z; Pecchi, E; Salvat, C | 1 |
| Chi, XX; Li, C; Nicol, GD; Strong, JA; Xie, W; Zhang, JM | 1 |
| Guerrero, M; Kays, J; Li, C; Li, JN; Nicol, GD | 1 |
1 review(s) available for organophosphonates and dinoprostone
| Article | Year |
|---|---|
Expression and function of phospholipase A(2) in brain.
Topics: Animals; Arachidonic Acids; Astrocytoma; Brain; Brain Neoplasms; Cyclooxygenase 2; Dinoprostone; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Inflammation; Interleukin-1; Isoenzymes; Lipopolysaccharides; Membrane Proteins; Mice; Organophosphonates; Phospholipases A; Polymerase Chain Reaction; Prostaglandin-Endoperoxide Synthases; Protein Binding; Rats; Tumor Cells, Cultured | 2002 |
14 other study(ies) available for organophosphonates and dinoprostone
| Article | Year |
|---|---|
Phosphonate-phospholipid analogues inhibit human phospholipase A2.
Topics: Arthritis, Rheumatoid; Calcimycin; Cell Line; Dinoprostone; Eicosanoids; Escherichia coli; Humans; In Vitro Techniques; Male; Monocytes; Neutrophils; Organophosphonates; Phospholipases A; Phospholipases A2; Phospholipids; SRS-A; Synovial Fluid | 1991 |
Bone-resorbing agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue.
Topics: Acetazolamide; Animals; Bone and Bones; Bone Resorption; Calcitonin; Calcitriol; Cells, Cultured; Collagenases; Cycloheximide; Dinoprostone; Enzyme Precursors; Fetus; Heparin; Hydroxyurea; Interleukin-1; Kinetics; Mice; Microbial Collagenase; Organophosphonates; Osteoclasts; Parathyroid Hormone; Prostaglandins E; Recombinant Proteins; Tretinoin; Triamcinolone; Tumor Necrosis Factor-alpha | 1988 |
On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs.
Topics: Blood Platelets; Dinoprostone; Epoprostenol; Humans; Hydantoins; Organophosphonates; Organophosphorus Compounds; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Prostaglandins D; Prostaglandins E; Receptors, Cell Surface; Receptors, Prostaglandin; Structure-Activity Relationship | 1984 |
Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells.
Topics: Arachidonic Acids; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Division; Cholangiocarcinoma; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Dinoprost; Dinoprostone; Enzyme Inhibitors; Flavonoids; Hepatocyte Growth Factor; Humans; Imidazoles; Interleukin-6; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; Nitrobenzenes; Organophosphonates; Phospholipases A; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfonamides; Tumor Cells, Cultured | 2002 |
Multidrug resistance protein 4 (ABCC4)-mediated ATP hydrolysis: effect of transport substrates and characterization of the post-hydrolysis transition state.
Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Beryllium; Biological Transport; Catalysis; Cations; Cell Line; Cell Membrane; Chelating Agents; Cobalt; Dinoprostone; DNA, Complementary; Dose-Response Relationship, Drug; Edetic Acid; Fluorides; Humans; Hydrolysis; Insecta; Kinetics; Magnesium; Manganese; Methotrexate; Models, Biological; Multidrug Resistance-Associated Proteins; Nucleotides; Organophosphonates; Protein Binding; Substrate Specificity; Vanadates; Zidovudine | 2004 |
Effects of the N-methyl-D-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity.
Topics: Analgesics; Animals; Azabicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dinoprostone; Excitatory Amino Acid Antagonists; Hot Temperature; Male; Morphine; Organophosphonates; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2005 |
Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Arachidonic Acids; Bacterial Proteins; Bacterial Toxins; Cell Line; Dinoprostone; Eicosanoids; Endothelial Cells; Epoprostenol; Female; Group IV Phospholipases A2; Humans; Ibuprofen; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Masoprocol; Mice; Mice, Inbred BALB C; Organophosphonates; Phospholipases A; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Effects of pyrrophenone, an inhibitor of group IVA phospholipase A2, on eicosanoid and PAF biosynthesis in human neutrophils.
Topics: Arachidonic Acids; Dinoprostone; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; Group IV Phospholipases A2; Humans; In Vitro Techniques; Leukotrienes; Neutrophils; Organophosphonates; Phospholipase D; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Pyrrolidines | 2006 |
Arachidonic acid inhibits osteoblast differentiation through cytosolic phospholipase A2-dependent pathway.
Topics: 3T3 Cells; Alkaline Phosphatase; Animals; Arachidonic Acid; Arachidonic Acids; Cell Differentiation; Cell Shape; Clone Cells; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Dinoprostone; Enzyme Inhibitors; Fibroblasts; Indomethacin; Mice; Nitrobenzenes; Organophosphonates; Osteoblasts; Phospholipases A; Phospholipases A2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; RNA, Messenger; Sulfonamides | 2007 |
The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
Topics: Amidohydrolases; Analgesics, Opioid; Animals; Arachidonic Acids; Benzamides; Benzomorphans; Cannabinoid Receptor Modulators; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperalgesia; Indoles; Male; Morphine; Organophosphonates; Pain; Pain Measurement; Piperazines; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
Endocannabinoid 1 and 2 (CB(1); CB(2)) receptor agonists affect negatively cow luteal function in vitro.
Topics: Adenine; Adenosine; Animals; Arachidonic Acids; Cattle; Corpus Luteum; Dinoprost; Dinoprostone; Female; In Vitro Techniques; Indoles; Organophosphonates; Piperidines; Pregnancy; Progesterone; Pyrazoles; Pyrrolidines; Random Allocation; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2009 |
Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.
Topics: Acrylamides; Animals; Cells, Cultured; Chondrocytes; Cytokines; Dinoprostone; Gene Expression Regulation; Humans; Inflammation; Insulin; Mice; Mice, Knockout; Naphthalenes; Nicotinamide Phosphoribosyltransferase; Organophosphonates; Piperidines; Receptor, IGF Type 1; Receptor, Insulin; Signal Transduction | 2012 |
Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor.
Topics: Action Potentials; Analysis of Variance; Anilides; Animals; Capsaicin; Cell Line, Tumor; Cell Movement; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Ganglia, Spinal; Guanosine Diphosphate; Hyperalgesia; Lysophospholipids; Male; Melanoma; Mice; Organophosphonates; Pain Threshold; Patch-Clamp Techniques; Pertussis Toxin; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sensory Receptor Cells; Sensory System Agents; Sphingosine; Thionucleotides; Time Factors; Wound Healing | 2012 |
Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Topics: Action Potentials; Anilides; Animals; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Fingolimod Hydrochloride; Ganglia, Spinal; Gene Expression Regulation; Immunosuppressive Agents; Lysophospholipids; Mice; Mice, Inbred C57BL; Organophosphonates; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA, Small Interfering; Sensory Receptor Cells; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazolidines | 2015 |